UNIGE document Scientific Article
previous document  unige:33098  next document
add to browser collection
Title

Phase I trial of concomitant hyperfractionated radiotherapy with docetaxel and cisplatin for locally advanced head and neck cancer

Authors
Published in Cancer Journal. 2006, vol. 12, no. 1, p. 63-8
Abstract This study was conducted to determine the maximum tolerated dose of docetaxel when administered concomitantly with radical hyperfractionated radiotherapy and cisplatin in patients with locally advanced head and neck cancer.
Keywords AgedAntineoplastic Combined Chemotherapy Protocols/administration & dosage/adverse effectsCarcinoma, Squamous Cell/pathology/therapyCisplatin/administration & dosage/adverse effectsCombined Modality TherapyDeglutition Disorders/etiologyDose FractionationDose-Response Relationship, DrugFemaleHead and Neck Neoplasms/pathology/therapyHumansMaleMaximum Tolerated DoseMiddle AgedMucositis/etiologyNeck DissectionNeoplasm StagingTaxoids/administration & dosage/adverse effectsTreatment Outcome
Identifiers
PMID: 16613664
Full text
Article (Published version) (77 Kb) - public document Free access
Structures
Research groups Groupe Dulguerov Pavel (ORL et chirurgie cervico-faciale) (145)
Groupe Becker Minerva (imagerie ORL) (683)
La recherche translationnelle en oncologie (654)
Citation
(ISO format)
ALLAL, Abdelkarim Said et al. Phase I trial of concomitant hyperfractionated radiotherapy with docetaxel and cisplatin for locally advanced head and neck cancer. In: Cancer Journal, 2006, vol. 12, n° 1, p. 63-8. https://archive-ouverte.unige.ch/unige:33098

222 hits

203 downloads

Update

Deposited on : 2014-01-10

Export document
Format :
Citation style :